Professor Voors is chairing a research group of students, MD-PhD-fellows and post-docs mainly on using –omics data to increase our knowledge on pathophysiology leading to personalized therapies in heart failure. He is an editorial board member of the European Journal of Heart Failure, Clinical Research in Cardiology Cardiovascular Drugs and Therapy, the Journal of Cardiovascular Medicine, and Heart Failure Reviews. He is/was involved as principal investigator/executive/steering committee member of 44 clinical trials on novel therapies in acute and chronic heart failure. Prof. Voors was a member of the 2012 ESC Heart Failure Guidelines Committee, and is the co-chair of the 2016 ESC Heart Failure Guidelines. He has authored more than 500 peer-reviewed papers and several books and chapters and his Hirsch-index is 81.